LGND Competitors - Ligand Pharmaceuticals Incorporated logo

LGND Competitors

Ligand Pharmaceuticals Incorporated

$307.19
+$5.38(+1.78%)
69
Overall
75
Value
63
Tech
71
Quality
How is this score calculated?
Market Cap
$6.02B
Volume
75.69K
52W Range
$175.89 - $326.63
Target Price
$344.25

LGND competitors: AMGN, SPPI, GSK, MRK, PFE. Ligand Pharmaceuticals Incorporated is compared with its Healthcare peers on market cap, P/E ratio, dividend yield and performance.

LGND Competitors Compared

CompanyPriceMarket capEPS est. (current yr)Dividend yieldMarketXLS Rank
AMGN Amgen Inc.$414.87$224.29B$22.942.40%65
GSK GSK plc$46.50$92.88B$4.813.90%33
MRK Merck & Co., Inc.$145.60$359.22B$2.762.34%74
PFE Pfizer Inc.$28.28$161.19B$2.986.08%70
ABCD
1SymbolPriceChangeVol
2LGND$307.19+1.8%75.69K
3
4
5
6

Get Ligand Pharmaceuticals Incorporated Data in Excel

Stream real-time data directly to your spreadsheets

BUY NOW
Stock data provided by MarketXLS.